Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

=================

CHAMPIONS TACKLING MS - AWARDS Dinner, Honoring Aaron Boster, MD and Jon e. Glaser, DDS - now open for registration. Visit www.events.msvn.org

Saturday, January 7, 2012

Study Finds Age-Related Effects in MS may be Reversible



Newswise — BOSTON – January 6, 2012 – Scientists at Joslin Diabetes Center, Harvard University, and the University of Cambridge have found that the age-related impairment of the body’s ability to replace protective myelin sheaths, which normally surround nerve fibers and allow them to send signals properly, may be reversible, offering new hope that therapeutic strategies aimed at restoring efficient regeneration can be effective in the central nervous system throughout life.
In a proof-of-principle study published in the journal Cell Stem Cell, the researchers report that defects in the regeneration of the myelin sheaths surrounding nerves, which are lost in diseases such as multiple sclerosis may be at least partially corrected following exposure of an old animal to the circulatory system of a young animal. Myelin is a fatty substance that protects nerves and aids in the quick transmission of signals between nerve cells.

Read More


..
..Comments for each blog posting are always appreciated. 
     Please use the link found below, to leave comments.. .. All comments are moderated to reduce SPAM and bad language
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 Click to: REGISTER For our MS weekly e-Newsletter
"Providing You with 'MS Views and News', IS What We Do"   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Help us to educate $ DONATE NOW PLEASE $

"MS Views and News"  is a 501©(3) Not-For-Profit organization
 as recognized by the Internal Revenue Service

All contributions are tax deductible to the fullest extent allowed by law
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
..............................

Spray pump used for first cannabis-based prescription medicine launched in Germany





Spray pump used for first cannabis-based prescription medicine launched in Germany in the field of spasticity in multiple sclerosis management.

GW Pharmaceuticals and Aptar Pharmadeveloped a mouth spray device that allows Sativex® and a cannabinoid medicine to be delivered to multiple sclerosis patients suffering from muscle spasticity.
According to Aptar Pharma, Sativex Oromucosal Spray is the first approved cannabis-based prescription medicine to be launched in Germany in the field of spasticity in MS management. The medicine is sprayed into the mouth either onto the inside of the cheek or under the tongue to provide patients with a flexible dosing regime.
Sativex was recently approved in Germany and Denmark, and has been launched in the U.K., Spain, and Canada. The medicine is marketed in the U.K. and Canada by Bayer Healthcare AG.








..
..Comments for each blog posting are always appreciated. 
     Please use the link found below, to leave comments.. .. All comments are moderated to reduce SPAM and bad language
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 Click to: REGISTER For our MS weekly e-Newsletter
"Providing You with 'MS Views and News', IS What We Do"   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Help us to educate $ DONATE NOW PLEASE $

"MS Views and News"  is a 501©(3) Not-For-Profit organization
 as recognized by the Internal Revenue Service

All contributions are tax deductible to the fullest extent allowed by law
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
..............................

TAU discovers better model to find MS cure






Scientists use mice with type 1 diabetes that actually develop MS; breakthrough could lead to better treatments


All laboratory research on multiple sclerosis have been conducted until now using experimental autoimmune encephalomyelitis (EAE) as mouse model, even though it is not the same as MS. Mice with EAE – a scientific model first created in the 1920s – are raised by injecting the rodents with protein from myelin – the insulating material on the nerves that breaks down and in humans causes the disease. The myelin is then mixed with bacteria.

The mouse’s immune system attacks the myelin and produces an autoimmune-like response, which causes the disease in humans, but as bacteria are not involved in the debilitating neurological disease MS, it is not the same mechanism.



But now, Tel Aviv University researchers have discovered a better model – mice with type 1 diabetes that actually develop MS and can thus be used to test the mechanisms and potential treatments. The researchers hope this breakthrough could lead eventually to the development of better treatments and maybe one day a cure. The research was recently published in Experimental Neurology.

In people, the “shorting” of electrical signals inhibits their transfer between neurons, often leading to devastating disabilities such as blindness and paralysis. Active periods of MS last for anywhere between a few minutes to weeks. These attacks are caused by lesions in the brain that develop, partly recover and then recur. The more attacks there are, the greater the risk of permanent disability.



Israeli scientists are among the prime developers of medications such as Copaxone that shorten attacks and reduce their intensity. But research into a potential cure has often been stymied by the lack of a genuine animal model for the human disease. MS does not present in this model as it does in human sufferers – most mouse models experience a single inflammatory peak that leaves them with permanentsymptoms such muscle paralysis. But the damage can be detected in the spinal cord, not in the brain.


Read More

..Comments for each blog posting are always appreciated. 
     Please use the link found below, to leave comments.. .. All comments are moderated to reduce SPAM and bad language
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 Click to: REGISTER For our MS weekly e-Newsletter
"Providing You with 'MS Views and News', IS What We Do"   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Help us to educate $ DONATE NOW PLEASE $

"MS Views and News"  is a 501©(3) Not-For-Profit organization
 as recognized by the Internal Revenue Service

All contributions are tax deductible to the fullest extent allowed by law
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
..............................

Thursday, January 5, 2012

Treatment Advances for Multiple Sclerosis







~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
..............................

Symptom Management for Multiple Sclerosis



The National MS Society
and MS Learn Online invite you to view some of the most watched webcasts of 2011

The Best of 2011: 


  
Click here to view the webcast, or copy into your browser: http://www.nationalmssociety.org/multimedia-library/ms-learn-online/index.aspx
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
..............................

Wednesday, January 4, 2012

Latent Virus Sparks Inflammation in MS - more to do with EBV


By Crystal Phend, Senior Staff Writer, MedPage Today
Published: January 03, 2012
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco and
Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner


Epstein-Barr virus may play a role in multiple sclerosis (MS) by activating innate immune responses, researchers found.

Examination of postmortem brain tissue turned up RNA segments of the virus specifically in areas of active MS lesions overexpressing an inflammatory cytokine involved in innate immunity, according to a study by Ute C. Meier, DPhil, of Queen Mary University of London, and colleagues.

That cytokine, interferon-alpha, was overexpressed in active areas of white matter MS lesions but not in inactive lesions, normal-appearing white matter, or normal brain tissue from controls, the group reported online in Neurology.



Significantly higher densities of cells labeling for interferon-alpha were present in acute MS lesions (130 ± 9.4 cells/mm2) and active borders of chronic active MS lesions (114.8 ± 9.7 cells/mm2) compared with inactive MS lesions (18.22 ± 2.8 cells/mm2), normal-appearing white matter (4.4 ± 1.2 cells/mm2), and control tissue (12.25 ± 2 cells/mm2P<0.0001).

"Perhaps [the subtle role] is not too surprising as Epstein-Barr virus is a persistent virus with the aim to coexist rather than eradicate the host," the authors wrote.

The virus has a strong epidemiologic link to MS, they pointed out.
Individuals who have had a symptomatic case of infectious mononucleosis from Epstein-Barr virus are twice as likely to later develop MS, with risk appearing higher for smokers.

Determining the mechanism for the link to Epstein-Barr virus could aid in developing better treatments for the neurodegenerative disease, Meier's group suggested, and there could be broader implications as well.

"Our study casts new light on mechanistic interactions of viral RNAs and innate immune activation in the [central nervous system], and may highlight the propensity of latent viral infections to contribute to neuroinflammation in the CNS, not only in multiple sclerosis but also in other neuroinflammatory diseases," they wrote.

Their study revitalizes debate over how common Epstein-Barr virus-infected B cells are in MS brains and whether they are a driving factor, Jan D. L√ľnemann, of the University of Zurich, Switzerland, noted in an accompanying editorial.



READ MORE

..Comments for each blog posting are always appreciated. 
     Please use the link found below, to leave comments.. .. All comments are moderated to reduce SPAM and bad language
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 Click to: REGISTER For our MS weekly e-Newsletter
"Providing You with 'MS Views and News', IS What We Do"   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Help us to educate $ DONATE NOW PLEASE $

"MS Views and News"  is a 501©(3) Not-For-Profit organization
 as recognized by the Internal Revenue Service

All contributions are tax deductible to the fullest extent allowed by law
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
..............................

Tuesday, January 3, 2012

Copaxone repairs nerve tissue in multiple sclerosis patients



Teva reported the results of a 12-month MRI study on the evolution of multiple sclerosis lesions.

3 January 12 16:47, Globes' correspondent


Copaxone repairs nerve tissue in multiple sclerosis patients, said Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) today in reporting the results of a 12-month MRI study on the evolution of multiple sclerosis lesions. The study was published in the January issue of "Frontiers in Bioscience".
“These data indicate that treatment with Copaxone resulted in a measureable amount of tissue repair in study patients,” said the lead research Dr. Robert Zivadinov, Director of the Buffalo Neuroimaging Analysis Center at the University at Buffalo. “The observed increases in magnetization transfer ratio (MTR) point to a potential for remyelination. Overall, these findings contribute to the vast body of research that supports the long-term efficacy and safety of the therapy."
The researchers found that multiple sclerosis patients treated with Copaxone experienced significantly increased magnetization transfer ratio (MTR) - a nonconventional MRI technique used to investigate abnormalities in brain structures, and increased values indicate potential remyelination (re-generation of the nerve's myelin sheath) and axonal tissue repair in the patients' brains.




..Comments for each blog posting are always appreciated. 
     Please use the link found below, to leave comments.. .
. All comments are moderated to reduce SPAM and bad language
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 Click to: REGISTER For our MS weekly e-Newsletter
"Providing You with 'MS Views and News', IS What We Do"   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Help us to educate $ DONATE NOW PLEASE $

"MS Views and News"  is a 501©(3) Not-For-Profit organization
 as recognized by the Internal Revenue Service

All contributions are tax deductible to the fullest extent allowed by law
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
..............................